{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:45:31Z","timestamp":1765889131715},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,19]]},"DOI":"10.7759\/cureus.40661","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T01:40:16Z","timestamp":1687225216000},"source":"Crossref","is-referenced-by-count":1,"title":["Treatment of Relapsed B\/T-cell Mixed Phenotype Acute Leukemia With Blinatumomab"],"prefix":"10.7759","author":[{"given":"Yasmeen","family":"Abdo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey D","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarika P","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carter P","family":"Milner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talal","family":"Hilal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.064485","article-title":"Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification","volume":"97","author":"Yan L","year":"2012","unstructured":"Yan L, Ping N, Zhu M, et al.. Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification. Haematologica. 2012, 97:1708-12. 10.3324\/haematol.2012.064485","journal-title":"Haematologica"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.202","article-title":"Mixed-phenotype acute leukemia: historical overview and a new definition","volume":"24","author":"Weinberg OK","year":"2010","unstructured":"Weinberg OK, Arber DA. Mixed-phenotype acute leukemia: historical overview and a new definition. Leukemia. 2010, 24:1844-51. 10.1038\/leu.2010.202","journal-title":"Leukemia"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25256","article-title":"Genomic and clinical characterization of B\/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations","volume":"93","author":"Mi X","year":"2018","unstructured":"Mi X, Griffin G, Lee W, et al.. Genomic and clinical characterization of B\/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations. Am J Hematol. 2018, 93:1358-67. 10.1002\/ajh.25256","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21703","article-title":"Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)\/ MLL-MLLT1(ENL), B\/T-lymphoid type: a first case report","volume":"85","author":"Naghashpour M","year":"2010","unstructured":"Naghashpour M, Lancet J, Moscinski L, Zhang L. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)\/ MLL-MLLT1(ENL), B\/T-lymphoid type: a first case report. Am J Hematol. 2010, 85:451-4. 10.1002\/ajh.21703","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0058-4","article-title":"Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis","volume":"32","author":"Maruffi M","year":"2018","unstructured":"Maruffi M, Sposto R, Oberley MJ, Kysh L, Orgel E. Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis. Leukemia. 2018, 32:1515-28. 10.1038\/s41375-018-0058-4","journal-title":"Leukemia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-821363","article-title":"International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia","volume":"132","author":"Hrusak O","year":"2018","unstructured":"Hrusak O, de Haas V, Stancikova J, et al.. International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia. Blood. 2018, 132:264-76. 10.1182\/blood-2017-12-821363","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2016.1161185","article-title":"Blinatumomab: a CD19\/CD3 bispecific T cell engager (BiTE) with unique anti-tumor efficacy","volume":"57","author":"Goebeler ME","year":"2016","unstructured":"Goebeler ME, Bargou R. Blinatumomab: a CD19\/CD3 bispecific T cell engager (BiTE) with unique anti-tumor efficacy. Leuk Lymphoma. 2016, 57:1021-32. 10.3109\/10428194.2016.1161185","journal-title":"Leuk Lymphoma"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609783","article-title":"Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia","volume":"376","author":"Kantarjian H","year":"2017","unstructured":"Kantarjian H, Stein A, G\u00f6kbuget N, et al.. Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia. N Engl J Med. 2017, 376:836-47. 10.1056\/NEJMoa1609783","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2018-0104","article-title":"Concomitant use of blinatumomab and donor lymphocyte infusion for mixed-phenotype acute leukemia: a case report with literature review","volume":"11","author":"Durer S","year":"2019","unstructured":"Durer S, Durer C, Shafqat M, et al.. Concomitant use of blinatumomab and donor lymphocyte infusion for mixed-phenotype acute leukemia: a case report with literature review. Immunotherapy. 2019, 11:373-8. 10.2217\/imt-2018-0104","journal-title":"Immunotherapy"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-314682","article-title":"Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification","volume":"117","author":"Matutes E","year":"2011","unstructured":"Matutes E, Pickl WF, Van't Veer M, et al.. Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood. 2011, 117:3163-71. 10.1182\/blood-2010-10-314682","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber DA","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al.. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016, 127:2391-405. 10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2015.03.012","article-title":"Survival of patients with mixed phenotype acute leukemias: a large population-based study","volume":"39","author":"Shi R","year":"2015","unstructured":"Shi R, Munker R. Survival of patients with mixed phenotype acute leukemias: a large population-based study. Leuk Res. 2015, 39:606-16. 10.1016\/j.leukres.2015.03.012","journal-title":"Leuk Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081974","article-title":"Mixed-phenotype acute leukemia: clinical diagnosis and therapeutic strategies","volume":"10","author":"George BS","year":"2022","unstructured":"George BS, Yohannan B, Gonzalez A, Rios A. Mixed-phenotype acute leukemia: clinical diagnosis and therapeutic strategies\r\n. Biomedicines. 2022, 10:1974. 10.3390\/biomedicines10081974","journal-title":"Biomedicines"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1694-4","article-title":"Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization","volume":"92","author":"Heesch S","year":"2013","unstructured":"Heesch S, Neumann M, Schwartz S, et al.. Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization. Ann Hematol. 2013, 92:747-58. 10.1007\/s00277-013-1694-4","journal-title":"Ann Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-012-1662-4","article-title":"Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimens","volume":"92","author":"Liu QF","year":"2013","unstructured":"Liu QF, Fan ZP, Wu MQ, et al.. Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimens. Ann Hematol. 2013, 92:679-87. 10.1007\/s00277-012-1662-4","journal-title":"Ann Hematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25317","article-title":"Treatment of CD19-positive mixed phenotype acute leukemia with blinatumomab","volume":"94","author":"El Chaer F","year":"2019","unstructured":"El Chaer F, Ali OM, Sausville EA, et al.. Treatment of CD19-positive mixed phenotype acute leukemia with blinatumomab. Am J Hematol. 2019, 94:E7-8. 10.1002\/ajh.25317","journal-title":"Am J Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/2040620719849496","article-title":"Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia","volume":"10","author":"Guerra VA","year":"2019","unstructured":"Guerra VA, Jabbour EJ, Ravandi F, Kantarjian H, Short NJ. Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia. Ther Adv Hematol. 2019, 10:2040620719849496. 10.1177\/2040620719849496","journal-title":"Ther Adv Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/162221-treatment-of-relapsed-bt-cell-mixed-phenotype-acute-leukemia-with-blinatumomab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:56Z","timestamp":1707509096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/162221-treatment-of-relapsed-bt-cell-mixed-phenotype-acute-leukemia-with-blinatumomab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.40661","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,19]]}}}